Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

65results about How to "Improve intake efficiency" patented technology

Slightly acidic environment targeted polypeptide modified tumor targeted nano drug delivery system, and preparation method thereof

The invention belongs to the field of biotechnology, and relates to a slightly acidic environment targeted polypeptide modified tumor targeted nano drug delivery system, and a preparation method thereof. The slightly acidic environment targeted polypeptide modified tumor targeted nano drug delivery system is prepared via self-assembly of a slightly acidic environment targeted polypeptide modified dendrimer encapsulated gene, wherein the surface of the dendrimer is rich of amino groups. According to the preparation method, a polypeptide of transmembrane helix protein C derived from bacteria visual purple is used for modifying a high molecular carrier, enrichment and adhesion onto cells is realized via a pH sensitive cell membrane insertion method, and entering into cells is realized via electrostatic adsorption guided endocytosis, so that untaking of tumor cells on drugs is improved, and toxic and side effects are reduced. According to the tumor targeted nano drug delivery system, cell membrane is taken as the target point, and the polypeptide is taken as the target head group in tumor slightly acidic environment, targeting and curing efficiency are high, the preparation method is simple and convenient, and tumor cell drugs, which are derived from human or animal, and is used for targeted therapy, can be prepared.
Owner:FUDAN UNIV

Reconstitutable microecological gel for sea cucumber and abalone culture and preparation method thereof

The invention provides reconstitutable microecological gel for sea cucumber and abalone culture and a preparation method thereof and relates to sea cucumber and abalone breeding feed. The gel comprises, by mass ratio, kelp: nutritional agent: gel fixing agent: moisture=1:0-1: 0.016-0.15:0.2-3. The content of beneficial microorganisms is 1*104-1*1010 per gram. During preparation, the kelp is smashed, water and the nutritional agent are added and mixed evenly, the gel fixing agent is added, the mixture is mixed evenly and boiled, beneficial microbial suspension is added and mixed evenly after the temperature drops to below 50 DEG C, and the mixture is pour into a container to be cooled, solidified and dried so as to obtain the reconstitutable microecological gel for the sea cucumber and abalone culture. The reconstitutable microecological gel is formed by fixing various ingredients through algal polysaccharides, and the gel can be ingested by sea cucumbers or abalones after reconstitution and is used for embedding materials good for growth of the sea cucumbers and the abalones such as probiotics and the nutritional agent. The gel can be used effectively because the gel is prevented from being diluted by seawater.
Owner:THIRD INST OF OCEANOGRAPHY STATE OCEANIC ADMINISTATION

Carboxymethyl chitosan nanoparticles modified with glycyrrhizic acid, preparation method and application thereof

The invention belongs to the technical field of nano materials, and in particular relates to carboxymethyl chitosan nanoparticles modified with glycyrrhizic acid, as well as a preparation method and application thereof. The nanoparticles disclosed by the invention are in a core-shell type; a hydrophobic polymer serves as a kernel packaged medicament; and carboxymethyl chitosan serves as a hydrophilic shell and is covalently linked with hepatic targeting ligand glycyrrhizic acid. The preparation method comprises the following steps of: firstly grating and copolymerizing carboxymethyl chitosan and hydrophobic monomers and self-assembling to form nanoparticles in the action of an initiator; secondly, oxidizing glycyrrhizic acid to obtain a glycyrrhizic acid aldehyde solution, mixing the glycyrrhizic acid aldehyde solution with the nanoparticles at a certain proportion and introducing targeting groups, and carrying out ultrasonic loading on the medicament. Compared with the prior art, the preparation method is simple and easy to control and has good repeatability and better stability and safety; and the targeting property and the tumor-inhabiting effect of the anti-tumor medicament can be strengthened remarkably. The nanoparticles serve as a targeting delivery vector for hydrophobic medicaments or molecular probes and can be used for treatment and diagnosis of liver diseases.
Owner:FUDAN UNIV

Self-oxygen-supply hollow Prussian blue nanoparticle as well as preparation method and application thereof

The invention discloses a self-oxygen-supply hollow Prussian blue nanoparticle and a preparation method and application thereof. The self-oxygen-supply hollow Prussian blue nanoparticle is provided with a hollow Prussian blue nanoparticle body, hemoglobin and IR783 are loaded on a mesoporous shell layer and an internal hollow structure of the hollow Prussian blue nanoparticle body, the drug loading capacity of the hemoglobin is 61.5%-63.5%, and the drug loading capacity of the IR783 is 24.2%-27.5%. The self-oxygen-supply hollow Prussian blue nanoparticle loaded with hemoglobin and IR783 prepared by the invention can improve the condition of insufficient oxygen supply in photodynamic therapy; in addition, since the half-life period of active oxygen generated by the photodynamic therapy is very short and the active oxygen is effective only in a relatively short distance, loading of IR783 with a mitochondrial targeting function is conducted in the invention, the self-oxygen-supply hollow Prussian blue nanoparticle body loaded with hemoglobin and IR783 is conveyed to mitochondria, so a mitochondrial function is destroyed, photodynamic therapy effect is remarkably improved, and tumor cell apoptosis is promoted.
Owner:HUAQIAO UNIVERSITY

Antineoplastic hydrogel polypeptide and preparation method

The invention provides antineoplastic hydrogel polypeptide and a preparation method. The polypeptide comprises a self-assembling structural domain at the C end and a killing structural domain at the Nend, and the self-assembling structural domain is connected with the killing structural domain through a flexible structural domain. According to an antineoplastic melittin hydrogel slow-releasing agentia, the antineoplastic hydrogel polypeptide carries antineoplastic active polypeptide to obtain the agentia. The preparation method comprises the following steps that 1), an antineoplastic hydrogelpolypeptide aqueous solution and an antineoplastic active polypeptide aqueous solution are prepared; 2), the antineoplastic hydrogel polypeptide aqueous solution and the antineoplastic active polypeptide aqueous solution which are prepared in the step 1) are mixed to obtain a mixed solution; 3), an NaCl solution is dropwise added into the mixed solution prepared in the step S2 until the concentration of the NaCl solution is 0.9%, and after standing, the antineoplastic melittin hydrogel slow-releasing agentia is prepared. The technical purposes of promotion of the uptaking efficiency of activepolypeptide cells, cytoplasm location, preparation of the antineoplastic hydrogel polypeptide and the preparation method can be achieved.
Owner:XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV

Tumor-targeting double-drug carrying and delivery system and preparation method thereof

The invention belongs to the field of biotechnology, and specifically, relates to a tumor-targeting double-drug carrying and delivery system and a preparation method thereof. The tumor-targeting double-drug carrying and delivery system adopts high-molecular materials, polyethylene glycol, a polypeptide, a treatment gene and a chemotherapeutic drug, wherein the polypeptide is utilized as a targeting head and the high-molecular materials are utilized as base high-molecular carriers. The preparation method comprises that the chemotherapeutic drug of adriamycin and the like are inserted into double chains of the treatment gene to form a gene-chemotherapeutic drug compound; and through electrostatic interaction between the gene chemotherapeutic compound and the base high-molecular carriers, the tumor-targeting double-drug carrying and delivery system which simultaneously carries the treatment gene and the chemotherapeutic drug is obtained. The high-molecular materials are novel polypeptide-modified high-molecular materials, are selected by a phage display technology, and can enter into cells by endocytosis, and thus the gene and chemotherapeutic drug intake capability of tumor cells are improved and safety is improved. The polypeptide (T7) as the targeting head has advantages belonging to transferrin, can effectively avoid interferences from endogenous transferrin, has high targeting and treatment efficiency, is easy for preparation, and can be further developed and be utilized for targeting treatment on other tumor tissue.
Owner:FUDAN UNIV

Preparation method of mesoporous apatite nano-drug carrier with reduction responsiveness and cellular targeting property for hepatoma cell

The invention discloses a preparation method of a mesoporous apatite nano-drug carrier with reduction responsiveness and cellular targeting property for a hepatoma cell, belonging to the field of biomedical materials. The invention aims at solving the problems that the current drug carrier is high in toxic and side effects and low in degradability. The preparation method comprises the steps of firstly, preparing a template agent; secondly, preparing a mesoporous hydroxylapatite nanoparticle; thirdly, aminating mesoporous hydroxylapatite; fourthly, carboxylating mesoporous apatite; fifthly, preparing disulfide bond functionalized mesoporous apatite; and sixthly, preparing the mesoporous apatite nano-drug carrier with reduction responsiveness and cellular targeting property. The mesoporous apatite nano-drug carrier prepared by using the preparation method can be used for recognizing hepatoma cells in a targeting way, so that the uptake of the normal tissues to the drug is reduced, and the in-vivo toxic and side effects of the drug are reduced. The drug is regularly and quantitatively introduced to pathological tissues, so that the utilization ratio of the drug is increased.
Owner:HARBIN INST OF TECH

Preparation method of ultra-small-size iron oxide nanoparticles and application thereof

InactiveCN110680931ADoes not affect positive reinforcement propertiesInefficient uptakeNanomagnetismFerric oxidesPhysical chemistryIron oxide nanoparticles
The invention provides a preparation method of ultra-small-size iron oxide nanoparticles. The method comprises the following steps: dissolving ferric acetylacetonate in diethylene glycol with the concentration of 0.02-0.16 mol/L in the diethylene glycol, carrying out thermal decomposition on ferric acetylacetonate in an inert gas environment at 200-220 DEG C until a reaction system is converted into a black solution from reddish brown, and carrying out steps of heating reflux, cooling, separating and purifying. The invention further provides an application of the ultra-small-size iron oxide nanoparticles prepared by the preparation method in preparation of an MRI cell tracer. The preparation method is simple, the preparation method is simple, various parameters are easy to control, the prepared iron oxide nanoparticles are accurately controlled within the range of 2-5 nm, the prepared iron oxide nanoparticles are very sensitive to the influence of water quantum MRI signals of marked cells, the positive contrast of the ultra-small-size iron oxide nanoparticles serving as a contrast agent is enhanced, and positive enhancement is displayed for magnetically marked cells in an MRI image.
Owner:SUZHOU INST OF BIOMEDICAL ENG & TECH CHINESE ACADEMY OF SCI

Application of heterocyclic compound containing at least two sulfur atoms to preparation of nano vaccine and prepared nano vaccine

The invention relates to the technical field of immunotherapy or vaccine prevention and treatment, in particular to a heterocyclic compound containing two or more sulfur atoms and an application of the heterocyclic compound to preparation of a nano vaccine. The invention provides an application of the heterocyclic compound which contains at least two sulfur atoms and can be covalently or non-covalently connected with polypeptide to preparation of the nano vaccine. Nanoparticles prepared by self-assembly of the compound and an antigen can enter dendritic cytoplasm in a transmembrane mode, and the uptake efficiency of the antigen and an immunologic adjuvant is improved. In the process of entering the cells, biodegradation of an enzyme body in lysosome on antigens or nucleic acid adjuvants can be effectively avoided or reduced, so that the nano vaccine disclosed by the invention can efficiently activate the dendritic cells and improve the cross presentation effect on the antigens, further CD8 + T cells can be effectively activated, and proliferation of the T cells can be promoted. Therefore, the nano vaccine provided by the invention can prevent tumor cell proliferation and virus infection by utilizing efficient immune activation and immune regulation effects.
Owner:苏州维益生物科技有限公司

Biomimetic multifunctional lipoprotein nanoparticle modified by biological peptide and preparation method and application thereof

The invention discloses a biomimetic multifunctional lipoprotein nanoparticle modified by biological peptide and a preparation method and application thereof, the multifunctional biomimetic lipoprotein nanoparticle is composed of a biomimetic lipoprotein nano-carrier shell modified by biological peptide and a nano-form drug core, and the carrier shell is composed of apolipoprotein bionic peptide, biological peptide and natural phospholipid substitute. The preparation method comprises a film dispersion method and an emulsification evaporation method. The preparation method disclosed by the invention is simple and mild in condition and low in cost, and the prepared biological peptide modified biomimetic multifunctional lipoprotein nanoparticle has the advantages of high drug loading capacity, high biomimetic property, strong penetrability, biological safety, lesion site targeting property, drug loading mode diversity and the like. A nano-drug delivery platform can realize 'diagnosis and treatment integration' and 'multi-mode combined treatment', and can realize timely diagnosis and efficient treatment of complex progressive diseases such as tumors, neurodegenerative diseases and the like.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Glutathione response type double-loading medicine polymer micelle and preparation method and application thereof

The invention discloses glutathione response type double-loading medicine polymer micelle and a preparation method and application thereof and belongs to the field of biological medical engineering materials. The preparation method disclosed by the invention is mild and simple and avoids special treatment. The prepared double-loading medicine polymer micelle disclosed by the invention has the advantages of good water solubility and good biocompatibility; furthermore, metabolite of the double-loading medicine polymer micelle is easy to degrade and has smaller toxicity; ingredients of the double-loading medicine polymer micelle are simple, the raw materials are easy to obtain, and the double-loading medicine polymer micelle is hopeful to be widely applied to the field of biological and medical engineering materials. The micelle can be used for wrapping hydrophobic drug; meanwhile, a positive-electricity high molecular material can carry gene medicine through electrostatic interaction toform a double-loading medicine carrier to give play to a synergistic effect. As polypeptide has a modifying effect, the polypeptide has the ability of entering tumor cells; furthermore, gene medicineand hydrophobic medicine can inhibit growth of tumor cells through different mechanisms, so that a treating effect of the polymer micelle to the tumor cells is improved; thus, the double-loading medicine polymer micelle has a wide application prospect in compound chemotherapy for malignant tumors.
Owner:JINAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products